Tokyo, Sept. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059094) titled 'Investigation of endoscopic gastric cancer screening combined with AI as an alternative to double check system' on Sept. 16.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Single blind -participants are blinded
Control - No treatment
Primary Sponsor:
Institute - Hokkaido Cancer Society
Condition:
Condition - Gastric cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To clarify whether endoscopic gastric cancer screening using AI can replace double-checking.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Combining AI with gastric cancer endoscopic screening
Interventions/Control_2 - Non-combining AI with gastric cancer endoscopic screening
Eligibility:
Age-lower limit - 50
years-old
=
Gender - Male and Female
Key inclusion criteria - Those who have undergone endoscopic gastric cancer screening
Key exclusion criteria - Participants who did not complete the endoscopy examination
Participants who were determined to require further examination but did not undergo further examination
Participants who the principal investigator determined to be unsuitable as study subjects
Patients who are unable to express their own will due to dementia or impaired consciousness
Patients who are unable to give consent
Target Size - 10834
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 03 Month 18 Day
Date of IRB - 2025 Year 03 Month 28 Day
Anticipated trial start date - 2025 Year 09 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065389
Disclaimer: Curated by HT Syndication.
